Produkty 2260669-17-6

CAS 2260669-17-6 występuje w naszej ofercie pod nazwami: 7α–hydroxy–4–Cholesten–3–one–d7, 7α-Hydroxycholestenone-d7, 7α-Hydroxy-4-cholesten-3-one-d7, 98.0%, 7 alpha-hydroxycholestenone-D7. Oferty producentów: GLPBio, Biosynth, MedChemExpress, Sigma-Aldrich. Dostępne opakowania: 500μg, 5mg, 1mg, 10mg, 50mg, 25mg, 500 μg.

7α–hydroxy–4–Cholesten–3–one–d7
GLPBio
  • opakowanie: 500μg
  • Warianty: 1
od 4383,56
Zobacz produkt
7α-Hydroxycholestenone-d7
Biosynth
  • opakowanie: 5mg, 1mg, 10mg, 50mg
  • Warianty: 5
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one-d7, 98.0%
MedChemExpress
  • opakowanie: 500 μg
  • Warianty: 1
od 8038,02
Zobacz produkt
7 alpha-hydroxycholestenone-D7
Sigma-Aldrich
  • opakowanie: 10MG, 1MG
  • Warianty: 2
od 3780,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 2260669-17-6) to związek chemiczny o wzorze sumarycznym C27H44O2 i masie molowej 407.7 g/mol. Nazwa systematyczna IUPAC: (7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: IOIZWEJGGCZDOL-CTNVFXSSSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O2
Masa molowa407.7 g/mol
Nazwa IUPAC(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyIOIZWEJGGCZDOL-CTNVFXSSSA-N
SMILES[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](CC4=CC(=O)CC[C@]34C)O)C)C([2H])([2H])[2H]

Dane obliczone przez PubChem (NCBI)

Synonimy: 7alpha-hydroxy-4-cholesten-3-one-d7, 7?-Hydroxy-4-cholesten-3-one-d7, 7a-Hydroxy-4-cholesten-3-one-d7, 7Alpha-Hydroxy-4-cholesten-3-one-d7 (contains 2% d0), (7a)-7-Hydroxycholest-4-en-3-one-d7; 7a-Hydroxycholest-4-en-3-one-d7;, 7?-Hydroxycholestenone-d7, 7a-Hydroxy-4-cholesten-3-one-d7 (contains 2% d0)
Powiązane formy tego związku
(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
(7S,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
(7S,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
Izomery (ten sam wzór sumaryczny)
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
[(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate C27H44O2
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O2
(1S)-3-[(Z)-2-[(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O2
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-7,7,7-trideuterio-6-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-4-[(2S)-3,3-dimethyloxiran-2-yl]butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O2
(1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
(8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
(3S,9R,10S,13R,14R,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O2